Immatics
gen in melanoma targeted to enter registration enabling phase trial in | Immatics
Company
Deck date
November 2023
Slide
24 of 75
Related slides by other companies
Results
May 2021
Investor Presentation
September 2022
Investor Presentation
November 2024
Results
February 2021
Other recent decks by Immatics
Results
October 2022
Search Thousands of Presentations by World Leading Companies